Khaled Alshabani

Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical Center

Kayoko Hayakawa, Sureka Gattu, Dror Marchaim et al. · Antimicrobial Agents and Chemotherapy · 2013 · 71 citations · Full text

Pathogen Detection, Escherichia Coli, Antibiotic Resistance +23

Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit

Nassar Al-Zubaidi, Emad Shehada, Khaled Alshabani et al. · Hematology/Oncology and Stem Cell Therapy · 2018 · 42 citations · Full text

Epidemiology of Vancomycin-Resistant Enterococcus faecalis: a Case-Case-Control Study

Kayoko Hayakawa, Dror Marchaim, Mohan Palla et al. · Antimicrobial Agents and Chemotherapy · 2012 · 41 citations · Full text

Electronic inhaler monitoring and healthcare utilization in chronic obstructive pulmonary disease

Khaled Alshabani, Amy Attaway, Michael J. Smith et al. · Journal of Telemedicine and Telecare · 2019 · 35 citations

Impact of Different Antimicrobial Therapies on Clinical and Fiscal Outcomes of Patients with Bacteremia Due to Vancomycin-Resistant Enterococci

Kayoko Hayakawa, Emily T. Martin, Uma Mahesh Gudur et al. · Antimicrobial Agents and Chemotherapy · 2014 · 27 citations · Full text